Who are the top longevity series c investors & vc firms?

Top longevity series c investors & vc firms include Khosla Ventures, OrbiMed, GV (Google Ventures), Alumni Ventures, Foresite Capital, Portfolia, Longitude Capital, SV Health Investors — 54 firms in total meet the criteria.

Fund	HQ	Invests	Stage	Check	CRM
Khosla Ventures 51 people · Leads rounds	Menlo Park	US	Pre-Seed–Late Stage	$5K – $50M	+ Add to CRM
OrbiMed 131 people · Leads rounds	New York	US	Pre-Seed–Late Stage	$1M – $75M	+ Add to CRM
GV (Google Ventures) 54 people · Leads rounds	Mountain View	US	Seed–Late Stage	$250K – $50M	+ Add to CRM
Alumni Ventures 33 people · Follows rounds	Manchester	US	Pre-Seed–Late Stage	$100K – $10M	+ Add to CRM
Foresite Capital 62 people	West Hollywood	US	Pre-Seed–Late Stage	—	+ Add to CRM
Portfolia 79 people · Follows rounds	San Mateo	US	Seed–Late Stage	$10K	+ Add to CRM
Longitude Capital 78 people · Leads rounds	Menlo Park	US	Series A–Late Stage	$10M – $30M	+ Add to CRM
SV Health Investors 30 people · Leads rounds	Boston	US	Pre-Seed–Late Stage	$1M – $20M	+ Add to CRM
Obvious Ventures 41 people · Leads rounds	San Francisco	US	Pre-Seed–Late Stage	$250K – $6M	+ Add to CRM
Novo Holdings 47 people	Copenhagen	DK	Pre-Seed–Late Stage	$1.1M – $54M	+ Add to CRM
MPM BioImpact 50 people	Boston	US	Pre-Seed–Late Stage	$1M – $15M	+ Add to CRM
Basecamp Fund 12 people · Follows rounds	Manchester	US	Pre-Seed–Late Stage	$100K – $10M	+ Add to CRM
Catalio Capital Management, LP 36 people · Follows rounds	New York	US	Seed–Late Stage	—	+ Add to CRM
LIFTT 36 people · Leads rounds	Torino	IT	Pre-Seed–Late Stage	—	+ Add to CRM
EQT Life Sciences 42 people · Leads rounds	Luxembourg	LU	Seed–Late Stage	$11M – $66M	+ Add to CRM
Advent Life Sciences 29 people	London	GB	Seed–Late Stage	—	+ Add to CRM
Casdin Capital 39 people · Follows rounds	New York	US	Seed–Series C	—	+ Add to CRM
Kfund 25 people	Madrid	ES	Pre-Seed–Growth	$108K – $10.8M	+ Add to CRM
Type One Ventures 25 people · Follows rounds	Los Angeles	US	Pre-Seed–Late Stage	$100K – $5M	+ Add to CRM
LSP (Life Sciences Partners) 41 people · Leads rounds	Amsterdam	NL	Series A–Late Stage	$10.8M – $64.8M	+ Add to CRM
Ahren Innovation Capital 34 people · Follows rounds	Cambridge, Cambridgeshire	GB	Pre-Seed–Late Stage	—	+ Add to CRM
HealthCap 34 people	Stockholm	SE	Seed–Growth	—	+ Add to CRM
K2 HealthVentures 27 people	Boston	US	Series A–Late Stage	$10M – $100M	+ Add to CRM
Lumira Ventures 18 people	Toronto	CA	Pre-Seed–Late Stage	$1M – $10M	+ Add to CRM

Longevity Series C Investors & VC Firms

Frequently asked questions

Related lists